# OnCo record fred-saad (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/fred-saad/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "fred-saad" ;
  schema:name "Fred Saad"@en ;
  schema:description "Montreal urologist who led the zoledronic acid trials in prostate cancer bone metastases and was lead author of ARANOTE, which established darolutamide plus hormone therapy for metastatic hormone-sensitive disease."@en ;
  schema:url <https://onco.cc/people/fred-saad/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "prostate", "trialist" ;
  schema:jobTitle "Professor and Chief of Urology, Centre hospitalier de l'Université de Montréal" ;
  onco:cancers <https://onco.cc/cancers/prostate-mhspc/>, <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/prostate/> ;
  onco:institutions <https://onco.cc/institutions/chum/> ;
  onco:trials <https://onco.cc/trials/aranote/> ;
  schema:affiliation <https://onco.cc/institutions/chum/> .
